IN8bio, Inc.INABNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P100
Near historical high
vs 2Y Ago
14.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202547.36%
2024-3.47%
20233.24%
2022-78.56%
2021-89.39%
2020-48.57%
2019-73.38%
20180.00%